Horizon Pharma plc Provides Comment on Express Scripts' Business Practices

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/28/2026

1. CDNS
2. FFIV
3. TFII
4. META
5. SPY
6. XFLT
7. NVDA
8. AAPL
9. AMZN
10. SPGI

Go back to Horizon Pharma plc Provides Comment on Express Scripts' Business Practices

Negative Press Doesn't Change UBS View on Horizon Pharma (HZNP)

November 12, 2015 9:14 AM EST

UBS analyst Marc Goodman, published a note on Horizon Pharma (NASDAQ: HZNP) in the wake of negative press:

Express Scripts (NASDAQ: ESRX) is suing Horizon for $140M of owed rebates under a contractual agreement that Horizon... More

Horizon Pharma (HZNP) Issues Commentary on Express Scripts' (ESRX) Business Practices

November 11, 2015 12:12 PM EST

(NOTE - The following follows an earlier statement made by Horizon.)

Horizon Pharma plc (Nasdaq: HZNP) commented on Express Scripts' (Nasdaq: ESRX) business practices.

"Our philosophy of ensuring that patients get the medicine their doctors prescribe is threatening Express Scripts' profiteering and exposing what we believe is a lack of care for... More

Linden Disruption Expected to Have 'Minimal Impact' on Horizon Pharma (HZNP) - Mizuho

November 11, 2015 11:57 AM EST

Mizuho Securities analyst Irina Koffler reiterated a Buy rating and $34 price target on Horizon Pharma (NASDAQ: HZNP), saying they expect minimal impact from Linden disruption.

Koffler commented, "We spoke with management and learned that Linden processes ~150-200 prescriptions for Duexis, Vimovo, Pennsaid, and... More